Figure 2.
Kaplan-Meier analysis of the time to first occurrence of death or graft loss of the ITT population showed a similar time to death or graft loss in the belatacept conversion group and in the CNI continuation group. No patient was imputed as having graft loss or death due to loss of follow-up.